Search - tctmd.com

Displaying 141 - 160 of 465

Sort: Relevancy | Date

Presentation TCT 2020

TCT 421: Clinical Outcomes of Catheter-Guided Renal Denervation for the Treatment of Heart Failure With Reduced Ejection Fraction

Presenter: Daniel Garcia

October 14, 2020

Presentation TCT 2020

TCT 420: Micro Dissection of the Human Renal Nervous System: Implications for Performing Renal Denervation Procedures

Presenter: Arturo Garcia-Touchard

October 14, 2020

Presentation TCT 2020

TCT 419: Patients With Resistant Hypertension in the Global SYMPLICITY Registry: Anti-Hypertensive Medication Burden and Changes in Blood Pressure out to 3 Years

Presenter: Markus Schlaich

October 14, 2020

Presentation TCT 2020

TCT 418: Evaluation of Nerve Injury and Regrowth Following Renal Denervation in Swine Model

Presenter: Andrew Sharp

October 14, 2020

Presentation TCT 2020

TCT 416: Powerful Antihypertensive Effect of Anatomically Optimized Distal Renal Denervation 3-Year After the Procedure According to a Double-Blind Randomized Controlled Study.

Presenter: Stanislav Pekarskiy

October 14, 2020

Presentation TCT 2019

Device-Based Autonomic Modulation in Renal Failure

Presenter: Roland Schmieder

September 28, 2019

Presentation TCT 2019

Device-Based Autonomic Modulation in Supraventricular and Ventricular Arrhythmias

Presenter: Christian Ukena

September 28, 2019

Presentation TCT 2019

Device-Based Autonomic Modulation in Heart Failure

Presenter: Michael Boehm

September 28, 2019

Presentation TCT 2019

Sensing Renal Nerve Activity Before, During, and After Denervation III: Pythagoras

Presenter: Joost Daemen

September 28, 2019

Presentation TCT 2019

Sensing Renal Nerve Activity Before, During, and After Denervation II: Symap

Presenter: Jie Wang

September 28, 2019

Presentation TCT 2019

Sensing Renal Nerve Activity Before, During, and After Denervation I: Autonomix

Presenter: Robert Schwartz

September 28, 2019

Presentation TCT 2019

What Are the Essential Differences Between Renal Denervation Devices and Procedures, and Do They Matter?

Presenter: Philipp Lurz

September 28, 2019

Presentation TCT 2019

Innovative Trial Designs in Device-Based Hypertension Treatment

Presenter: Konstantinos Tsioufis

September 28, 2019

Debate: Is a Clinical Outcomes Trial Mandatory Before Widespread Adoption of Device-Based Hypertension Therapies? - Yes, An Outcomes Study for Device-Based Hypertension Approaches Is Needed Before Widespread Use Can Be Recommended!

Presentation TCT 2019

Yes, An Outcomes Study for Device-Based Hypertension Approaches Is Needed Before Widespread Use Can Be Recommended!

Presenter: Bernard Gersh

September 28, 2019

Debate: Is a Clinical Outcomes Trial Mandatory Before Widespread Adoption of Device-Based Hypertension Therapies? - No: An Outcomes Study for Device-Based Hypertension Approaches Is NOT Necessary Before Widespread Use Can Be Recommended!

Presentation TCT 2019

No: An Outcomes Study for Device-Based Hypertension Approaches Is NOT Necessary Before Widespread Use Can Be Recommended!

Presenter: Andrew Sharp

September 28, 2019

Presentation TCT 2019

Device-Based Hypertension Treatments: Defining Responders and Predictors of Response

Presenter: Naomi Fisher

September 28, 2019

Presentation TCT 2019

Backbeat Update (Pacemaker-Mediated Baroreflex Stimulation)

Presenter: Daniel Burkhoff

September 28, 2019

Presentation TCT 2019

Update on ROX Trial Program (AV Fistula Creation)

Presenter: Melvin Lobo

September 28, 2019

Presentation TCT 2019

Update on CALM-II Trial (Endovascular Baroreflex Stimulation)

Presenter: Gregg Stone

September 28, 2019

Presentation TCT 2019

Magnitude of Antihypertensive Effect After Renal Denervation: Is It Sufficient for High-Risk as Well as Low-Risk Patients?

Presenter: Justin Davies

September 28, 2019

Advertisement

TCT 421: Clinical Outcomes of Catheter-Guided Renal Denervation for the Treatment of Heart Failure With Reduced Ejection Fraction

TCT 420: Micro Dissection of the Human Renal Nervous System: Implications for Performing Renal Denervation Procedures

TCT 419: Patients With Resistant Hypertension in the Global SYMPLICITY Registry: Anti-Hypertensive Medication Burden and Changes in Blood Pressure out to 3 Years

TCT 418: Evaluation of Nerve Injury and Regrowth Following Renal Denervation in Swine Model

TCT 416: Powerful Antihypertensive Effect of Anatomically Optimized Distal Renal Denervation 3-Year After the Procedure According to a Double-Blind Randomized Controlled Study.

Device-Based Autonomic Modulation in Renal Failure

Device-Based Autonomic Modulation in Supraventricular and Ventricular Arrhythmias

Device-Based Autonomic Modulation in Heart Failure

Sensing Renal Nerve Activity Before, During, and After Denervation III: Pythagoras

Sensing Renal Nerve Activity Before, During, and After Denervation II: Symap

Sensing Renal Nerve Activity Before, During, and After Denervation I: Autonomix

What Are the Essential Differences Between Renal Denervation Devices and Procedures, and Do They Matter?

Innovative Trial Designs in Device-Based Hypertension Treatment

Yes, An Outcomes Study for Device-Based Hypertension Approaches Is Needed Before Widespread Use Can Be Recommended!

No: An Outcomes Study for Device-Based Hypertension Approaches Is NOT Necessary Before Widespread Use Can Be Recommended!

Device-Based Hypertension Treatments: Defining Responders and Predictors of Response

Backbeat Update (Pacemaker-Mediated Baroreflex Stimulation)

Update on ROX Trial Program (AV Fistula Creation)

Update on CALM-II Trial (Endovascular Baroreflex Stimulation)

Magnitude of Antihypertensive Effect After Renal Denervation: Is It Sufficient for High-Risk as Well as Low-Risk Patients?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content